{
    "clinical_study": {
        "@rank": "68775", 
        "acronym": "ALLO-ASC", 
        "arm_group": [
            {
                "arm_group_label": "1 million cells/ml of ALLO-ASC", 
                "arm_group_type": "Experimental", 
                "description": "1 million cells/ml of ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) will be injected by ultrasound guided intervention."
            }, 
            {
                "arm_group_label": "10 million cells/ml of ALLO-ASC", 
                "arm_group_type": "Active Comparator", 
                "description": "10 million cells/ml of ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) will be injected by ultrasound guided intervention."
            }
        ], 
        "brief_summary": {
            "textblock": "Main purpose of this study is to evaluate efficacy and safety of allogenic adipose-derived\n      mesenchymal stem cells(ALLO-ASC) in treatment of tendon injury. ALLO-ASC will be\n      administrated to the patients with lateral epicondylitis by ultrasonographic guided\n      injection."
        }, 
        "brief_title": "Treatment of Tendon Injury Using Mesenchymal Stem Cells", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Lateral Epicondylitis", 
        "condition_browse": {
            "mesh_term": [
                "Tendon Injuries", 
                "Tennis Elbow", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "Injection volume depends on the size of lesion on ultrasound examination. And all injection\n      will be done under ultrasound guidance. First the investigators will administrate 1 million\n      cells/ml (Group 1 for 6 participants). After monitoring the safety of injection for 2 weeks\n      (the investigators will use WHO recommendations for grading of acute and subacute toxic\n      effects), the investigators decide to increase the quantity as 10 million cells/ml (Group 2\n      for participants).\n\n      The investigators will compare the efficacy difference as quantity increase. For efficacy\n      measurement, VAS/modified Mayo  clinic performance index for elbow/lesion measurement by\n      ultrasound will be used at 6 and 12 weeks after injections."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  clinically diagnosed as lateral epicondylitis (tennis elbow)\n\n          -  recurrent pain in spite of conservative treatment such as physical therapy,\n             medication, steroid injection\n\n          -  symptom duration is over 6 months\n\n          -  defect in common extensor tendon can be observed under ultrasound\n\n          -  patient that can understand the clinical trials\n\n        Exclusion Criteria:\n\n          -  patient that underwent other injection treatment within 6 weeks\n\n          -  some associated diseases (such as arthritis, synovitis, entrapment of related nerve,\n             radiculopathy to the target lesion, generalized pain syndrome, rheumatoid arthritis,\n             pregnancy, impaired sensibility, paralysis, history of allergic or hypersensitive\n             reaction to bovine-derived proteins or fibrin glue)\n\n          -  patient that enrolled other clinical trials within 30 days\n\n          -  history of drug/alcohol addiction, habitual smoker"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01856140", 
            "org_study_id": "SNUH-RM-SGChung-ASC-01"
        }, 
        "intervention": {
            "arm_group_label": [
                "1 million cells/ml of ALLO-ASC", 
                "10 million cells/ml of ALLO-ASC"
            ], 
            "intervention_name": "ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) injection", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "adipose derived mesenchymal stem cell", 
            "allogeneic stem cell"
        ], 
        "lastchanged_date": "November 22, 2013", 
        "location": {
            "contact": {
                "email": "suncg@snu.ac.kr", 
                "last_name": "Sun Gun Chung, MD, PhD", 
                "phone": "+82-2-2072-3954"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul National University College of Medicine"
            }, 
            "investigator": {
                "last_name": "Sun Gun Chung, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells(ALLO-ASC):A Pilot Study", 
        "overall_contact": {
            "email": "suncg@snu.ac.kr", 
            "last_name": "Sun Gun Chung, MD, PhD", 
            "phone": "+82-2-2072-3954"
        }, 
        "overall_contact_backup": {
            "email": "rehabilee@gmail.com", 
            "last_name": "Sang Yoon Lee, MD, MS", 
            "phone": "+82-2-2072-2967"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University College of Medicine", 
            "last_name": "Sun Gun Chung, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Korea: Food and Drug Administration", 
                "Korea: Ministry for Health, Welfare and Family Affairs"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in Visual analog scale (VAS) at 6 and 12 weeks", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 6 weeks, 12 weeks after intervention"
        }, 
        "reference": [
            {
                "PMID": "20970844", 
                "citation": "Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010 Nov 20;376(9754):1751-67. Epub 2010 Oct 21. Review."
            }, 
            {
                "PMID": "1991216", 
                "citation": "Price R, Sinclair H, Heinrich I, Gibson T. Local injection treatment of tennis elbow--hydrocortisone, triamcinolone and lignocaine compared. Br J Rheumatol. 1991 Feb;30(1):39-44."
            }, 
            {
                "PMID": "14523300", 
                "citation": "S\u00e1nchez M, Azofra J, Anitua E, And\u00eda I, Padilla S, Santisteban J, Mujika I. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc. 2003 Oct;35(10):1648-52."
            }, 
            {
                "PMID": "17910298", 
                "citation": "Johnson GW, Cadwallader K, Scheffel SB, Epperly TD. Treatment of lateral epicondylitis. Am Fam Physician. 2007 Sep 15;76(6):843-8. Review."
            }, 
            {
                "PMID": "7634730", 
                "citation": "S\u00f6lveborn SA, Buch F, Mallmin H, Adalberth G. Cortisone injection with anesthetic additives for radial epicondylalgia (tennis elbow). Clin Orthop Relat Res. 1995 Jul;(316):99-105."
            }, 
            {
                "PMID": "21048180", 
                "citation": "Maffulli N, Longo UG, Denaro V. Novel approaches for the management of tendinopathy. J Bone Joint Surg Am. 2010 Nov 3;92(15):2604-13. doi: 10.2106/JBJS.I.01744. Review."
            }, 
            {
                "PMID": "16735582", 
                "citation": "Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 2006 Nov;34(11):1774-8. Epub 2006 May 30."
            }, 
            {
                "PMID": "19380129", 
                "citation": "Kon E, Filardo G, Delcogliano M, Presti ML, Russo A, Bondi A, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. Injury. 2009 Jun;40(6):598-603. Epub 2009 Apr 19."
            }, 
            {
                "PMID": "17099241", 
                "citation": "S\u00e1nchez M, Anitua E, Azofra J, And\u00eda I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med. 2007 Feb;35(2):245-51. Epub 2006 Nov 12."
            }, 
            {
                "PMID": "7472743", 
                "citation": "Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res. 1995 Sep;13(5):655-63."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01856140"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Sun Gun Chung", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}